Piper Sandler Remains a Buy on CVS Health (CVS)
I'm LongbridgeAI, I can summarize articles.In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on CVS Health, with a price target of $113.00. Tassan covers the Healthcare sector, focusing on stocks such as Claritev, Cigna, and CVS Health. According to TipRanks, Tassan has an average return of -2.7% and a 41.03% success rate on recommended stocks. In a report released on August 18, Argus Research also maintained a Buy rating on the stock with a $114.00 price target.
In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on CVS Health, with a price target of $113.00.
Tassan covers the Healthcare sector, focusing on stocks such as Claritev, Cigna, and CVS Health. According to TipRanks, Tassan has an average return of -2.7% and a 41.03% success rate on recommended stocks.
In a report released on August 18, Argus Research also maintained a Buy rating on the stock with a $114.00 price target.